Cambridge Financial Group, Inc. - Q4 2013 holdings

$196 Billion is the total value of Cambridge Financial Group, Inc.'s 30 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 18.5% .

 Value Shares↓ Weighting
LNC SellLincoln Nat'l$7,778,463,000
+14.9%
150,687
-6.5%
3.97%
+6.3%
GILD SellGILEAD SCIENCES$7,607,405,000
+11.2%
101,297
-6.9%
3.88%
+2.8%
CAH SellCardinal Health$7,556,411,000
+19.8%
113,103
-6.5%
3.85%
+10.8%
JCI SellJohnson Controls$7,421,417,000
+15.9%
144,667
-6.2%
3.78%
+7.3%
BIIB SellBIOGEN IDEC INC$7,046,612,000
+1.8%
25,205
-12.3%
3.59%
-5.8%
BA SellBOEING CO$6,962,628,000
-0.0%
51,012
-13.9%
3.55%
-7.5%
MS SellMorgan Stanley$6,924,006,000
+12.4%
220,791
-3.4%
3.53%
+4.0%
XRX SellXerox$6,754,849,000
+17.3%
555,041
-0.8%
3.44%
+8.5%
ADM SellARCHER DANIELS MIDLAND CO$6,725,221,000
+12.9%
154,959
-4.2%
3.43%
+4.4%
MYL SellMylan Inc.$6,711,680,000
+11.5%
154,647
-1.9%
3.42%
+3.2%
ECL SellEcolab$6,698,305,000
-0.4%
64,240
-5.7%
3.42%
-7.9%
GD SellGeneral Dynamics$6,610,053,000
+5.0%
69,179
-3.8%
3.37%
-2.9%
BSX SellBoston Scientific Corp$6,401,287,000
-11.4%
532,553
-13.5%
3.26%
-18.0%
LMT SellLockheed Martin Corp.$6,376,473,000
+15.3%
42,893
-1.0%
3.25%
+6.7%
RF SellRegions Financial Corp$6,296,093,000
+3.4%
636,612
-3.2%
3.21%
-4.4%
MET SellMetLife Inc$6,289,175,000
+12.4%
116,639
-2.1%
3.21%
+4.0%
WAG SellWalgreen$6,269,059,000
-7.5%
109,141
-13.3%
3.20%
-14.4%
HAL SellHalliburton Co.$6,127,149,000
+1.6%
120,732
-3.6%
3.12%
-6.0%
SBUX SellStarbucks Corp$5,932,320,000
+0.5%
75,677
-1.3%
3.03%
-7.0%
BMS SellBemis Co$5,891,236,000
+3.4%
143,829
-1.5%
3.00%
-4.3%
UNH SellUnitedHealth Group$5,665,798,000
+4.7%
75,243
-0.4%
2.89%
-3.1%
F SellFord Motor Co$5,595,057,000
-12.2%
362,609
-4.0%
2.85%
-18.7%
HPQ ExitHEWLETT PACKARD CO$0-228,568
-100.0%
-2.64%
CVS ExitCVS CAREMARK$0-99,761
-100.0%
-3.12%
BAC ExitBank of America Corp$0-415,661
-100.0%
-3.16%
CSC ExitComputer Sciences$0-112,381
-100.0%
-3.21%
C ExitCitigroup$0-128,667
-100.0%
-3.44%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2014-02-20
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Target Corp42Q2 20244.3%
Sysco Corp42Q2 20245.9%
Cardinal Health42Q2 20245.0%
UnitedHealth Group37Q4 20224.5%
WALGREENS BOOTS ALLIANCE INC36Q2 20243.8%
Oneok35Q2 20245.4%
ARCHER DANIELS MIDLAND CO35Q4 20213.7%
Microsoft Corporation31Q2 20245.0%
Ryder System31Q2 20244.5%
MCDONALDS CORP30Q2 20244.1%

View Cambridge Financial Group, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-08-12
13F-HR2024-05-13
13F-HR2024-02-06
13F-HR2023-11-13
13F-HR2023-02-15
13F-HR2022-11-07
13F-HR2022-05-09
13F-HR2022-02-11
13F-HR2021-10-29
13F-HR2021-08-13

View Cambridge Financial Group, Inc.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (196061202000.0 != 196061201000.0)
  • The reported has been restated
  • The reported has been amended

Export Cambridge Financial Group, Inc.'s holdings